Not Yet RecruitingPhase 2ACTRN12610000848000

Does the perioperative use of Gabapentin reduce analgesia requirements in patients having delayed open reduction and internal fixation of forearm or ankle fractures?

Do patients who are having delayed open reduction and internal fixation of forearm or ankle fractures and who are given gabapentin peri-operatively, when compared with patients not given gabapentin, show lower narcotic analgesic requirements


Sponsor

Iain Salkield

Enrollment

50 participants

Start Date

Nov 5, 2010

Study Type

Interventional

Conditions

Summary

Gabapentin is a drug that is officially used to treat chronic pain. This study looks at whether it can help with the more acute pain from having broken bones in the wrist or ankle repaired with screws and plates. This is very painful for a relatively short period and if we find that gabapentin can help with this pain then this could become part of normal treatment.


Eligibility

Sex: Both males and femalesMin Age: 16 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether the medication gabapentin, given before and after surgery, can reduce pain and the need for painkillers in patients having wrist or ankle fracture repair surgery. It is for adults aged 16 and older who are able to use a patient-controlled pain pump.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Pre-operative and post-operative treatment with gabapentin for 24 hours. Preoperative dose would normally be 600 mg orally 30 minutes prior to surgery with 300 mg being given orally 8 hourly for 24 ho

Pre-operative and post-operative treatment with gabapentin for 24 hours. Preoperative dose would normally be 600 mg orally 30 minutes prior to surgery with 300 mg being given orally 8 hourly for 24 hours following completion of surgery. The doses would need to be reduced if a patient with moderate or worse renal failure was recruited.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000848000